by David E. Thurston
Chemistry and Pharmacology of Anticancer Drugs is a comprehensive survey of all families of anticancer agents currently in use or in advanced stages of clinical trials, including biologicals.
Features:
- Summarizes the fundamental causes of cancer, modes of treatment, and the philosophy of cancer drug discovery
- Brings together a broad spectrum of information relating to the chemistry and pharmacology of anticancer drugs and therapies
- Covers all types of anticancer drugs including biological agents and many in the research, development, and clinical evaluation stages
- Provides molecular structures and generic/trade names for each agent, along with information on chemistry, mechanism of action, and side effects/dose scheduling where appropriate
- Introduces cutting-edge research methodologies and tools being used to discover and develop new anticancer drugs and therapies
- Describes the new areas of oncogenomics and chemoprevention
Contents
Introduction to Cancer
- Metastases
- Diagnosis and Screening
- Formation of Cancer Cells (Tumorigenesis)
- Mechanisms of Genomic Damage
- Treatments
- Discovery of Anticancer Drugs and Preclinical Evaluation
- Accessibility of Drugs to Tumor Cells
- Achieving Selective Toxicity
- Limiting the Toxicity of Chemotherapeutic Agents
- Overview of Mechanisms of Action of Chemotherapeutic Agents
- Drug Resistance
- Combination Chemotherapy
- Use of Adjuvants
- Infertility Following Cancer Treatments
Antimetabolites
- DHFR Inhibitors (Antifolates)
- Purine Antimetabolites
- Pyrimidine Antimetabolites
- Thymidylate Synthase Inhibition
- Adenosine Deaminase Inhibition
- Ribonucleotide Reductase Inhibition
DNA Interactive Agents
- Alkylating Agents
- Cross-Linking Agents
- Intercalating Agents
- Topoisomerase Inhibitors
- DNA-Cleaving Agents
Antitubulin Agents
- Vinca Alkaloids
- The Taxanes
Molecularly Targeted Agents
- Kinase Inhibitors
- Inhibition of Ras Pathway Signaling
- Cell Cycle Inhibitors
- Proteasome Inhibitors
- mTOR Inhibitors
Hormonal Therapies
- Breast Cancer
- Prostatic Cancer
- Neuroendocrine Tumors: Somatostatin Analogs
- Estrogen Therapy
- Progestogen Therapy
Tumor-Targeting Strategies
- Antibody-Based Approaches
- Vascular-Targeting Strategies
- X-DEPT (Biphasic) Strategies
- Enzymatic Targeting
- Photoactivated Drugs (Photodynamic Therapy)
- Boron Neutron Capture Therapy
- Novel Drug Delivery Approaches
Biological Agents
- Biological Response Modifiers
- Immunotherapy
- Enzyme-Based Therapies
- Vaccines
The Future
- Novel Biological Targets and Therapeutic Strategies
- New Research Tools and Methodologies
- Chemopreventive Agents
Personalized Treatments
- Screening for Risk of Disease Development
- Prognosis and Staging
- Screening for Risk of Recurrence of Disease
- Selecting Best Treatments for Patients
- Predicting Side Effects of Chemotherapeutic Agents
- Pharmacogenomics in Clinical Trials
Adjunct Therapies
- Anti-emetic Agents
- Steroidal Agents
- Adjuvent Enzymes
Index